Theratechnologies Inc T.TH

Expectations with tesamorelin in NASH/NAFLD should be high

[Joemare]

They need to drive off-label use.  That's how it's done in pharma. He knows it too.  
Enough hiding your head in the sand.
Zero interest in NASH for the last three years.  He has a drug. There are studies proving efficacy.
They need to drive this componant. 
Something needs to make the SP needle move now.  This is becoming an embarrassement.

[Trogarzon]

They will lose their Nasdaq listing, they will lose their shareholders, they will lose their R&D programs if they don't get the stock price moving back to 2$+.  They know this but they are incapable of doing anything about it apart from trying to bake the pudding.  I'm not shure this will get us across the river.  I hope Soleus and others take control of the situation.

[Mannequin]

how can they legally do this or can they?  

[Joemare]

Common in pharma. no excuses. enough excuse. Check out ozempic

[Trogarzon]

What did we hire this guy for again.  The board kicked Luc out for this lame excuse of a CEO and we voted this board for another year of the same to come.

[jfm1330]

In the US, doctors are allowed to prescribe a drug for off label use, but pharmas cannot promote off label use and insurance companies are likely to not reimburse it. So how many patients are rich enough to pay totally for Egrifta and will have a doctor willing to prescribe it off label? Not many. In fact, almost nobody. Off label use of Ozempic for obesity is now so important that doctors don'